JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today. To our valued friends and shareholders,...
THCT plans for growth with focus on potential acquisitions in the Cannabis and Psychedelics industries - THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission...
Groundbreaking Leap Forward in THCT's New Business Plan. LAS VEGAS, NV / ACCESSWIRE / September 10, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission...
Jonathan Cross, a private equity fund manager with over 33 years of experience, joins THC Therapeutics LAS VEGAS, NV / ACCESSWIRE / August 31, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking,...
THCT Investigating Unique Strategy in Precious Metals Industry With a Special Interest in Silver Assets LAS VEGAS, NV / ACCESSWIRE / May 26, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded...
THCT has signed a contract with Dr. Dean to introduce and negotiate an agreement between THC Therapeutics and one or more well-known celebrities in the cannabis industry that will join the board of directors...
THCT has leveraged the extensive market research commissioned through Keyhole Research to redesign the dHydronator® for the consumer market. This new design is in the rapid prototyping phasein preparation...